Interestingly, we found that there was no significant difference on the expression level of PTGES3 between tumor and normal tissues in several cancer types, including kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), and prostate adenocarcinoma (PRAD), which belongs to genitourinary cancer. Here, PTGES3 is linked to prostate adenocarcinoma.